BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33107994)

  • 1. Sirolimus for patients with progressive epithelioid hemangioendothelioma.
    Smrke AM; Huang PH; Jones RL
    Cancer; 2021 Feb; 127(4):504-506. PubMed ID: 33107994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Retrospective Review of the Use of Sirolimus for Pediatric Patients With Epithelioid Hemangioendothelioma.
    Engel ER; Cournoyer E; Adams DM; Stapleton S
    J Pediatr Hematol Oncol; 2020 Nov; 42(8):e826-e829. PubMed ID: 31714437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case-series analysis within the Italian Rare Cancer Network.
    Stacchiotti S; Simeone N; Lo Vullo S; Baldi GG; Brunello A; Vincenzi B; Palassini E; Dagrada G; Collini P; Morosi C; Greco FG; Sbaraglia M; Dei Tos AP; Mariani L; Frezza AM; Casali PG
    Cancer; 2021 Feb; 127(4):569-576. PubMed ID: 33107985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Molecular Insights, and the Role of Systemic Therapies and Collaboration for Treatment of Epithelioid Hemangioendothelioma (EHE).
    Stacchiotti S; Tap W; Leonard H; Zaffaroni N; Baldi GG
    Curr Treat Options Oncol; 2023 Jun; 24(6):667-679. PubMed ID: 37058275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database.
    Stacchiotti S; Provenzano S; Dagrada G; Negri T; Brich S; Basso U; Brunello A; Grosso F; Galli L; Palassini E; Libertini M; Colia V; Gronchi A; Dei Tos AP; Crippa F; Morosi C; Pilotti S; Casali PG
    Ann Surg Oncol; 2016 Sep; 23(9):2735-44. PubMed ID: 27334221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.
    Stacchiotti S; Miah AB; Frezza AM; Messiou C; Morosi C; Caraceni A; Antonescu CR; Bajpai J; Baldini E; Bauer S; Biagini R; Bielack S; Blay JY; Bonvalot S; Boukovinas I; Bovee JVMG; Boye K; Brodowicz T; Callegaro D; De Alava E; Deoras-Sutliff M; Dufresne A; Eriksson M; Errani C; Fedenko A; Ferraresi V; Ferrari A; Fletcher CDM; Garcia Del Muro X; Gelderblom H; Gladdy RA; Gouin F; Grignani G; Gutkovich J; Haas R; Hindi N; Hohenberger P; Huang P; Joensuu H; Jones RL; Jungels C; Kasper B; Kawai A; Le Cesne A; Le Grange F; Leithner A; Leonard H; Lopez Pousa A; Martin Broto J; Merimsky O; Merriam P; Miceli R; Mir O; Molinari M; Montemurro M; Oldani G; Palmerini E; Pantaleo MA; Patel S; Piperno-Neumann S; Raut CP; Ravi V; Razak ARA; Reichardt P; Rubin BP; Rutkowski P; Safwat AA; Sangalli C; Sapisochin G; Sbaraglia M; Scheipl S; Schöffski P; Strauss D; Strauss SJ; Sundby Hall K; Tap WD; Trama A; Tweddle A; van der Graaf WTA; Van De Sande MAJ; Van Houdt W; van Oortmerssen G; Wagner AJ; Wartenberg M; Wood J; Zaffaroni N; Zimmermann C; Casali PG; Dei Tos AP; Gronchi A
    ESMO Open; 2021 Jun; 6(3):100170. PubMed ID: 34090171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO).
    Chevreau C; Le Cesne A; Ray-Coquard I; Italiano A; Cioffi A; Isambert N; Robin YM; Fournier C; Clisant S; Chaigneau L; Bay JO; Bompas E; Gauthier E; Blay JY; Penel N
    Cancer; 2013 Jul; 119(14):2639-44. PubMed ID: 23589078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The heterogeneity of Epithelioid Hemangioendothelioma (EHE): A case series and review of the literature with emphasis on treatment options.
    Witte S; Weidema M; Kaal S; Versleijen-Jonkers Y; Flucke U; van der Graaf W; Desar I
    Semin Oncol; 2021 Apr; 48(2):111-118. PubMed ID: 34176654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cell malignancies in infants, children and adolescents: Treatment results of three Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
    Sparber-Sauer M; Koscielniak E; Vokuhl C; Schmid I; Bien E; Seitz G; Hallmen E; von Kalle T; Scheer M; Münter M; Bielack SS; Niggli F; Ljungman G; Fuchs J; Hettmer S; Rössler J; Klingebiel T;
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28095. PubMed ID: 31814291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelioid hemangioendothelioma of the retroperitoneum - a rare vascular tumor.
    Sigala F; Galyfos G; Koniaris E; Barkolias C; Artsitas S; Zografos K; Filis K; Zografos G; Alexakis N
    Vasa; 2021 Jul; 50(4):312-316. PubMed ID: 32697157
    [No Abstract]   [Full Text] [Related]  

  • 11. The patient perspective on sirolimus for epithelioid hemangioendothelioma (EHE): results of a community survey highlighting the importance of equitable access to treatments.
    Robinson D; Leonard H; Baldi GG; Tap WD; Jones RL; Stacchiotti S; Pantziarka P
    Front Oncol; 2024; 14():1367237. PubMed ID: 38469238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epithelioid hemangioendothelioma].
    Cousin S; Le Loarer F; Crombé A; Karanian M; Minard-Colin V; Penel N
    Bull Cancer; 2019 Jan; 106(1):73-83. PubMed ID: 30527817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature.
    Frezza AM; Ravi V; Lo Vullo S; Vincenzi B; Tolomeo F; Chen TW; Teterycz P; Baldi GG; Italiano A; Penel N; Brunello A; Duffaud F; Hindi N; Iwata S; Smrke A; Fedenko A; Gelderblom H; Van Der Graaf W; Vozy A; Connolly E; Grassi M; Benjamin RS; Broto JM; Grignani G; Jones RL; Kawai A; Tysarowski A; Mariani L; Casali PG; Stacchiotti S
    Cancer Med; 2021 Apr; 10(8):2645-2659. PubMed ID: 33713582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment.
    Rosenberg A; Agulnik M
    Curr Treat Options Oncol; 2018 Mar; 19(4):19. PubMed ID: 29546487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant pleuropulmonary epithelioid hemangioendothelioma - unusual presentation of an aggressive angiogenic neoplasm.
    Mucientes P; Gomez-Arellano L; Rao N
    Pathol Res Pract; 2014 Sep; 210(9):613-8. PubMed ID: 24939148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characterization and long-term outcomes in pediatric epithelioid hemangioendothelioma.
    Cournoyer E; Al-Ibraheemi A; Engel E; Chaudry G; Stapleton S; Adams DM
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28045. PubMed ID: 31724797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common Secondary Genomic Variants Associated With Advanced Epithelioid Hemangioendothelioma.
    Seligson ND; Awasthi A; Millis SZ; Turpin BK; Meyer CF; Grand'Maison A; Liebner DA; Hays JL; Chen JL
    JAMA Netw Open; 2019 Oct; 2(10):e1912416. PubMed ID: 31577358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term outcomes of combined therapy with sirolimus and interferon-alpha 2b for advanced hepatic epithelioid hemangioendothelioma.
    Liu X; Zhou R; Liu L; Si S; Yang S; Han D; Tan H
    Ther Adv Med Oncol; 2024; 16():17588359231220509. PubMed ID: 38188469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelioid hemangioendotheliomas of the liver and lung in children and adolescents.
    Hettmer S; Andrieux G; Hochrein J; Kurz P; Rössler J; Lassmann S; Werner M; von Bubnoff N; Peters C; Koscielniak E; Sparber-Sauer M; Niemeyer C; Mentzel T; Busch H; Boerries M
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Expression of CAMTA1 Distinguishes Epithelioid Hemangioendothelioma From Histologic Mimics.
    Doyle LA; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2016 Jan; 40(1):94-102. PubMed ID: 26414223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.